Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes by Stuart E. Samuels, MD, PhD, Matthew H. Stenmark, MD, Jae Y. Lee, MD, PhD, Jonathan B. McHugh, MD, James A. Hayman, MD, Mark B. Orringer, MD, Susan G. Urba, MD, Libin Sun, MD, Congying Xie, PhD, Feng-Ming Kong, MD, PhD, Kyle C. Cuneo, MD

Get full text